---
figid: PMC3910500__nihms530933f6
figlink: /pmc/articles/PMC3910500/figure/F6/
number: Figure 6
caption: 'Canonical PI3K and MAPK pathway activation determined by reverse phase protein
  arrays and compared between GBM subclasses: Proneural (P, purple, n=55) and Mesenchymal
  (M, red, n=45). Activation/expression levels are plotted for principal signaling
  nodes of the MAPK (phospho-MEK and phospho-p90RSK), PI3 kinase (pS473-Akt) and mTOR
  (TSC1/2, phospho-mTOR, p235/236 S6, phospho-4EBP1 and EIF4E) pathways (p-values,
  two-tailed T-test). Mesenchymal tumors showed increased activation of the MAPK pathway
  (evidenced by higher levels of phospho-MEK and downstream phospho-p90RSK) and decreased
  levels of phospho-ERK inhibitory target TSC2. In contrast, proneural tumors showed
  relatively elevated expression and activation of members of the PI(3) kinase pathway
  including Akt PDK1 target site threonine 308 (p=0.01, not shown) and Akt mTORC2
  target site (serine 473). Phospho-ERK levels were not significantly different between
  these two subtypes.'
pmcid: PMC3910500
papertitle: The Somatic Genomic Landscape of Glioblastoma.
reftext: Cameron W. Brennan, et al. Cell. ;155(2):462-477.
pmc_ranked_result_index: '92280'
pathway_score: 0.9086314
filename: nihms530933f6.jpg
figtitle: 'Canonical PI3K and MAPK pathway activation determined by reverse phase
  protein arrays and compared between GBM subclasses: Proneural (P, purple, n=55)
  and Mesenchymal (M, red, n=45)'
year: ''
organisms: Homo sapiens
ndex: 1bb5ddce-df07-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3910500__nihms530933f6.html
  '@type': Dataset
  description: 'Canonical PI3K and MAPK pathway activation determined by reverse phase
    protein arrays and compared between GBM subclasses: Proneural (P, purple, n=55)
    and Mesenchymal (M, red, n=45). Activation/expression levels are plotted for principal
    signaling nodes of the MAPK (phospho-MEK and phospho-p90RSK), PI3 kinase (pS473-Akt)
    and mTOR (TSC1/2, phospho-mTOR, p235/236 S6, phospho-4EBP1 and EIF4E) pathways
    (p-values, two-tailed T-test). Mesenchymal tumors showed increased activation
    of the MAPK pathway (evidenced by higher levels of phospho-MEK and downstream
    phospho-p90RSK) and decreased levels of phospho-ERK inhibitory target TSC2. In
    contrast, proneural tumors showed relatively elevated expression and activation
    of members of the PI(3) kinase pathway including Akt PDK1 target site threonine
    308 (p=0.01, not shown) and Akt mTORC2 target site (serine 473). Phospho-ERK levels
    were not significantly different between these two subtypes.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPKAP1
  - RICTOR
  - MTOR
  - RPS6KA2
  - MLST8
  - PIK3CB
  - TSC1
  - KRAS
  - AKT1
  - EIF4EBP1
  - HRAS
  - MAPK1
  - IRS1
  - RPS6KA6
  - MAP2K2
  - MAP2K1
  - RPTOR
  - PIK3CG
  - BRAF
  - RPS6KA1
  - AKT3
  - TSC2
  - AKT2
  - RPS6KA4
  - MAPK3
  - PIK3R4
  - RPS6KA3
  - PIK3CD
  - PDK1
  - ARAF
  - RAF1
  - RPS6KA5
  - EIF4E
  - NRAS
  - PIK3CA
  - PIK3R5
  - PIK3R3
  - PIK3R6
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MAPKAP1
  entrez: '79109'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: RICTOR
  entrez: '253260'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA2
  entrez: '6196'
- word: MTORC2
  symbol: mTORC2
  source: bioentities_symbol
  hgnc_symbol: MLST8
  entrez: '64223'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: TSC1/2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: 4EBP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IRS1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA6
  entrez: '27330'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA1
  entrez: '6195'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Tuberin
  symbol: tuberin
  source: hgnc_alias_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA4
  entrez: '8986'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA3
  entrez: '6197'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: P90RSK
  symbol: P90RSK
  source: bioentities_symbol
  hgnc_symbol: RPS6KA5
  entrez: '9252'
- word: EIF4E
  symbol: EIF4E
  source: hgnc_symbol
  hgnc_symbol: EIF4E
  entrez: '1977'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: TSC1/2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: p-MEK,p<0.01
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: p-MEK,p<0.01
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
